In SPS, an animal model that effectively mimics PTSD, intranasal OXT administration reversed SPS-induced fear extinction repair and downregulated the levels of inflammatory factors (IL-1β, TNF-α) in the hippocampus and serum [63]. This evidence concerns the gene IL1B and post-traumatic stress disorder.